Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1α/vascular endothelial growth factor system

Journal of Orthopaedic Research

Volumn 24, Issue 4, 2006, Pages 653-663

  Mori, Shigeshi ^a   Akagi, Masao ^a   Kikuyama, Aiichiro ^a   Yasuda, Yoshiko ^a   Hamanishi, Chiaki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Axial shortening; Callus; Distraction osteogenesis; Hypoxia inducible factor (HIF 1 ); Vascular endothelial growth factor (VEGF)

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CYCLINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; ALKALINE PHOSPHATASE; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; BONE RADIOGRAPHY; CALLUS; CELL PROLIFERATION; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; EXTERNAL FIXATOR; HISTOLOGY; LEG LENGTHENING; MALE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RABBIT; TIBIA; TRABECULAR BONE; ANIMAL; ANIMAL MODEL; BONE DEVELOPMENT; BONE REGENERATION; GROWTH, DEVELOPMENT AND AGING; IMMUNOHISTOCHEMISTRY; METABOLISM; PHYSIOLOGY;

ALKALINE PHOSPHATASE; ANIMALS; BONE DENSITY; BONE REGENERATION; BONY CALLUS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MODELS, ANIMAL; OSTEOGENESIS; OSTEOGENESIS, DISTRACTION; PROLIFERATING CELL NUCLEAR ANTIGEN; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 33646177289     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20076     Document Type: Article

References (45)

1. De Bastiani G, Aldegheri R, Renzi-Brivio L, et al. 1987. Limb lengthening by callus distraction (callotasis). J Pediatr Orthop 7:129-134.
2. Hamanishi C, Yoshii T, Totani Y, et al. 1994. Lengthened callus activated by axial shortening. Histological and cytomorphometrical analysis. Clin Orthop 307:250-254.
3. Aronson J. 1994. Temporal and spatial increases in blood flow during distraction osteogenesis. Clin Orthop 301: 124-131.
4. Choi IH, Ahn JH, Chung CY, et al. 2000. Vascular proliferation and blood supply during distraction osteogenesis: a scanning electron microscopic observation. J Orthop Res 18:698-705.
5. Li G, Simpson AH, Kenwright J, et al. 1999. Effect of lengthening rate on angiogenesis during distraction osteogenesis. J Orthop Res 17:362-367.
6. Minematsu K, Tsuchiya H, Taki J, et al. 1998. Blood flow measurement during distraction osteogenesis. Clin Orthop 347:229-235.
7. Moore DC, Leblanc CW, Muller R, et al. 2003. Physiologic weight-bearing increases new vessel formation during distraction osteogenesis: a micro-tomographic imaging study. J Orthop Res 21:489-496.
8. Rowe NM, Mehrara BJ, Luchs JS, et al. 1999. Angiogenesis during mandibular distraction osteogenesis. Ann Plast Surg 42:470-475.
9. Ilizarov GA. 1989. The tension-stress effect on the genesis and growth of tissues. part-1, the influence of stability of fixation and soft-tissue preservation. Clin Orthop 238: 249-281.
10. Ilizarov GA. 1989. The tension-stress effect on the genesis and growth of tissues. part-2, the influence of the rate and frequency of distraction. Clin Orthop 239: 263-285.
11. Ferrara N, Davis-Smyth T. 1997. The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
12. Carlevaro MF, Cermelli S, Cancedda R, et al. 2000. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: autoparacrine role during endochondral bone formation. J Cell Sci 113:59-69.
13. Deckers MM, Karperien M, van der Bent C, et al. 2000. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141:1667-1674.
14. Ferguson C, Alpern E, Miclau T, et al. 1999. Does adult fracture repair recapitulate embryonic skeletal formation? Mech Dev 87:57-66.
15. Gerber HP, Vu TH, Ryan AM, et al. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
16. Hu J, Zou S, Li J, et al. 2003. Temporospatial expression of vascular endothelial growth factor and basic fibroblast growth factor during mandibular distraction osteogenesis. J Craniomaxillofac Surg 31:238-243.
17. Kim HH, Lee SE, Chung WJ, et al. 2002. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine 17:14-27.
18. Komatsu DE, Hadjiargyrou M. 2004. Activation of the transcription factor HIF-1 and its target genes, VEGF, HO-1, iNOS, during fracture repair. Bone 34:680-688.
19. Sawano A, Iwai S, Sakurai Y, et al. 2001. Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans. Blood 97:785-791.
20. Tatsuyama K, Maezawa Y, Baba H, et al. 2000. Expression of various growth factors for cell proliferation and cytodifferentiation during fracture repair of bone. Eur J Histochem 44:269-278.
21. Uchida S, Sakai A, Kudo H, et al. 2003. Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32:491-501.
22. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. 1999. Hypoxia regulates VEGF expression and cellular proliferation by osteoblasts in vitro. Plast Reconstr Surg 104: 738-747.
23. Semenza GL. 2004. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda) 19: 176-182.
24. Steinbrech DS, Mehrara BJ, Saadeh PB, et al. 2000. VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism. Am J Physiol Cell Physiol 278:C853-C860.
25. Carvalho RS, Einhorn TA, Lehmann W, et al. 2004. The role of angiogenesis in a murine tibial model of distraction osteogenesis. Bone 34:849-861.
26. Colnot CI, Helms JA. 2001. A molecular analysis of matrix remodeling and angiogenesis during long bone development. Mech Dev 100:245-250.
27. Pacicca DM, Patel N, Lee C, et al. 2003. Expression of angiogenic factors during distraction osteogenesis. Bone 33:889-898.
28. Pufe T, Wildemann B, Petersen W, et al. 2002. Quantitative measurement of the splice variants 120 and 164 of the angiogenic peptide vascular endothelial growth factor in the time flow of fracture healing: a study in the rat. Cell Tissue Res 309:387-392 (Epub 2002 Jul 17).
29. Saijo M, Kitazawa R, Nakajima M, et al. 2003. Heparanase mRNA expression during fracture repair in mice. Histochem Cell Biol 120:493-503 (Epub 2003 Nov 15).
30. Zelzer E, McLean W, Ng YS, et al. 2002. Skeletal defects in VEGF (120/ 120) mice reveal multiple roles for VEGF in skeletogenesis. Development 129:1893-1904.
31. Engsig MT, Chen QJ, Vu TH, et al. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879-889.
32. Midy V, Plouet J. 1994. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun 199:380-386.
33. Niida S, Kaku M, Amano H, et al. 1999. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190:293-298.
34. Street J, Bao M, deGuzman L, et al. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99:9656-9661 (Epub 2002 Jul 12).
35. Hamanishi C, Yoshii T, Totani Y, et al. 1994. Bone mineral density of lengthened rabbit tibia is enhanced by transplantation of fresh autologous bone marrow cells. An experimental study using dual X-ray absorptiometry. Clin Orthop 303:250-255.
36. Barleon B, Siemeister G, Martiny-Baron G, et al. 1997. Vascular endothelial growth factor upregulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 57:5421-5425.
37. Shen BQ, Lee DY, Gerber HP, et al. 1998. Homologous upregulation of KDR/ Flk-1 receptor expression by vascular endothelial growth factor in vitro. J Biol Chem 273:29979-29985.
38. Tokuda H, Kozawa O, Miwa M, et al. 2001. p38 mitogen-activated protein (MAP) kinase but not p44/p42 MAP kinase is involved in prostaglandin E1-induced vascular endothelial growth factor synthesis in osteoblasts. J Endocrinol 170:629-638.
39. Saadeh PB, Mehrara BJ, Steinbrech DS, et al. 1999. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 277:C628-C637.
40. Bouletreau PJ, Warren SM, Spector JA, et al. 2002. Factors in the fracture microenvironment induce primary osteoblast angiogenic cytokine production. Plast Reconstr Surg 110:139-148.
41. Saadeh PB, Mehrara BJ, Steinbrech DS, et al. 2000. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 141:2075-2083.
42. Akeno N, Robins J, Zhang M, et al. 2002. Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2alpha. Endocrinology 143:420-425.
43. Kozawa O, Matsuno H, Uematsu T. 2001. Involvement of p70 S6 kinase in bone morphogenetic protein signaling: vascular endothelial growth factor synthesis by bone morphogenetic protein-4 in osteoblasts. J Cell Biochem 81:430-436.
44. Wang CJ. 2003. An overview of shock wave therapy in musculoskeletal disorders. Chang Gung Med J 26:220-232.
45. Wang FS, Kuo YR, Wang CJ, et al. 2004. Nitric oxide mediates ultrasound-induced hypoxia-inducible factor-1alpha activation and vascular endothelial growth factor-A expression in human osteoblasts. Bone 35: 114-123.